Barclays’s ICU Medical ICUI Stock Holding History

Barclays’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-63,000	Closed	-$14.7M	–	4407
2021 Q3	$14.7M	Buy	+63,000	New	+$13.2M	0.01%	1017
2021 Q2	–	Sell	-17,500	Closed	-$3.6M	–	4954
2021 Q1	$3.6M	Buy	+17,500	New	+$3.7M	﹤0.01%	1792
2020 Q4	–	Sell	-5,500	Closed	-$1M	–	5027
2020 Q3	$1M	Sell	5,500 -2,300	-29%	-$433K	﹤0.01%	2691
2020 Q2	$1.44M	Sell	7,800 -12,200	-61%	-$2.42M	﹤0.01%	2428
2020 Q1	$4.04M	Buy	+20,000	New	+$3.85M	﹤0.01%	1655
2018 Q3	–	Sell	-10,000	Closed	-$2.94M	–	7236
2018 Q2	$2.94M	Buy	+10,000	New	+$2.73M	﹤0.01%	2196

Other funds holding ICUI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barclays's ICUI Position: Q1 2026 in Review

Barclays reduced its ICU Medical (ICUI) stake by 88% in Q1 2026, selling an estimated $4.75M and leaving 4,636 shares worth $599K. The position accounts for ﹤0.01% of the portfolio, ranked #3079.

Barclays first reported a position in ICUI in Q2 2013 and has held it in 50 quarters since. The position peaked at $34.5M in Q3 2021. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

Barclays held 4,636 shares of ICU Medical worth $599K as of Q1 2026.
Barclays sold 33,069 ICU Medical shares in Q1 2026, an estimated $4.75M.
ICU Medical made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3079 holding.
Barclays first reported a position in ICU Medical in Q2 2013 and has held it in 50 quarters since.
Barclays's ICU Medical position peaked at $34.5M in Q3 2021.
275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.